{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:25:26Z","timestamp":1794565526859,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-2600"],"award-info":[{"award-number":["2023-2600"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopsych.2026.04.022","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:02:25Z","timestamp":1784178145000},"page":"814-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["GLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies"],"prefix":"10.1016","volume":"100","author":[{"given":"Elisabet","family":"Jerlhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.04.022_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","article-title":"Alcohol use disorders","volume":"394","author":"Carvalho","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2026.04.022_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11920-019-0997-0","article-title":"Global burden of disease and the impact of mental and addictive disorders","volume":"21","author":"Rehm","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2026.04.022_bib3","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/S0140-6736(19)30726-3","article-title":"Alcohol and the global burden of disease","volume":"393","author":"Shield","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2026.04.022_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf028","article-title":"GLP-1 receptor agonists: Promising therapeutic targets for alcohol use disorder","volume":"166","author":"Jerlhag","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13679-018-0300-4","article-title":"Future pharmacotherapy for obesity: New anti-obesity drugs on the horizon","volume":"7","author":"Srivastava","year":"2018","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.biopsych.2026.04.022_bib6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.psyneuen.2012.11.009","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents","volume":"38","author":"Egecioglu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061965","article-title":"Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.04.022_bib8","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/acer.13199","article-title":"Effects of the GLP\u20131 agonist Exendin-4 on intravenous ethanol self-administration in mice","volume":"40","author":"S\u00f8rensen","year":"2016","journal-title":"Alcoholism Clin & Exp Res"},{"key":"10.1016\/j.biopsych.2026.04.022_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pbb.2017.07.014","article-title":"The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice","volume":"160","author":"Thomsen","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2026.04.022_bib10","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0443-18.2019","article-title":"Glucagon-like Peptide-1 receptor agonist treatment does not reduce abuse-related effects of opioid drugs","volume":"6","author":"Bornebusch","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.biopsych.2026.04.022_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00213-023-06367-x","article-title":"Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL\/6J mice","volume":"240","author":"D\u00edaz-Megido","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-018-5089-z","article-title":"Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys","volume":"236","author":"Thomsen","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/adb.12295","article-title":"The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents","volume":"21","author":"Vall\u00f6f","year":"2015","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599646","article-title":"Long-acting glucagon-like Peptide-1 receptor agonists suppress voluntary alcohol intake in Male Wistar Rats","volume":"14","author":"Marty","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.04.022_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41398-020-00923-1","article-title":"Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats","volume":"10","author":"Vall\u00f6f","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.04.022_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/dia.2019.0185","article-title":"Oral semaglutide: A review of the first oral glucagon-like peptide 1 receptor agonist","volume":"22","author":"Bucheit","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.biopsych.2026.04.022_bib17","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s42255-024-01113-9","article-title":"GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management","volume":"6","author":"Holst","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.biopsych.2026.04.022_bib18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obesity Metabolism"},{"key":"10.1016\/j.biopsych.2026.04.022_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104642","article-title":"Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats","volume":"93","author":"Aran\u00e4s","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.biopsych.2026.04.022_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1180512","article-title":"Antismoking agents do not contribute synergistically to semaglutide\u2019s ability to reduce alcohol intake in rats","volume":"14","author":"Aran\u00e4s","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170671","article-title":"The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission","volume":"8","author":"Chuong","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopsych.2026.04.022_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-024-06637-2","article-title":"Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys","volume":"242","author":"Fink-Jensen","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/bph.17406","article-title":"Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats","volume":"182","author":"Aran\u00e4s","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib24","first-page":"1","article-title":"The combination of a glucagon-like peptide-1 and amylin receptor agonists reduces alcohol consumption in both male and female rats","volume":"37","author":"Aran\u00e4s","year":"2024","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.biopsych.2026.04.022_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106119","article-title":"Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents","volume":"124","author":"Edvardsson","year":"2026","journal-title":"EBiomedicine"},{"key":"10.1016\/j.biopsych.2026.04.022_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188314","article-title":"Glucagon-like peptide-1 receptor agonists but not dipeptidyl peptidase-4 inhibitors reduce alcohol intake","volume":"135","author":"Farokhnia","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2026.04.022_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.68","article-title":"The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: Evidence from human genetic association studies and a mouse model of alcohol dependence","volume":"5","author":"Suchankova","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.04.022_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s11064-023-04093-6","article-title":"Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice","volume":"49","author":"Liu","year":"2024","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2026.04.022_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11011-014-9627-z","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats","volume":"30","author":"Sharma","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.biopsych.2026.04.022_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11011-014-9603-7","article-title":"Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats","volume":"30","author":"Sharma","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.biopsych.2026.04.022_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.physbeh.2016.04.013","article-title":"Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors","volume":"161","author":"Sirohi","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.04.022_bib32","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3390\/ijerph18052683","article-title":"Alcohol-induced blood-brain barrier impairment: An in vitro study","volume":"18","author":"Carrino","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.biopsych.2026.04.022_bib33","first-page":"209","article-title":"Alcohol, inflammation, and blood-brain barrier function in health and disease across development","volume":"161","author":"Vore","year":"2022","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psyneuen.2019.02.006","article-title":"Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents","volume":"103","author":"Vall\u00f6f","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib35","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.3390\/ijms21249710","article-title":"Brain site-specific inhibitory effects of the GLP-1 analogue Exendin-4 on alcohol intake and operant responding for palatable food","volume":"21","author":"Colvin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2026.04.022_bib36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1037\/pha0000620","article-title":"Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice","volume":"31","author":"Allingbjerg","year":"2023","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/adb.12583","article-title":"Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats","volume":"24","author":"Hernandez","year":"2019","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2019.02.020","article-title":"Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents","volume":"149","author":"Vall\u00f6f","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib39","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/acer.14437","article-title":"Glucagon-like Peptide-1 receptor signaling in the ventral tegmental area reduces alcohol self-administration in male rats","volume":"44","author":"Dixon","year":"2020","journal-title":"Alcoholism Clin & Exp Res"},{"key":"10.1016\/j.biopsych.2026.04.022_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.03.059","article-title":"Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure","volume":"1350","author":"Rinaman","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2026.04.022_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105684","article-title":"An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents","volume":"115","author":"Edvardsson","year":"2025","journal-title":"EBiomedicine"},{"key":"10.1016\/j.biopsych.2026.04.022_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110640","article-title":"Effects of glucagon-like peptide 1 receptor signaling in the dorsolateral septum on ethanol operant self-administration and relapse behaviors","volume":"279","author":"Xiao","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1176\/appi.ajp.2020.20030247","article-title":"Subjective responses to alcohol in the development and maintenance of alcohol use disorder","volume":"178","author":"King","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.04.022_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/appi.ajp.20240069","article-title":"Real-time assessment of alcohol reward, stimulation, and negative affect in individuals with and without alcohol use disorder and depressive disorders","volume":"182","author":"King","year":"2025","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.04.022_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-444-62619-6.00003-3","article-title":"Neurocircuitry of alcohol addiction: Synthesis from animal models","volume":"125","author":"Koob","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib46","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00213-025-06854-3","article-title":"Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats","volume":"243","author":"Windram","year":"2026","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2026.04.022_bib47","article-title":"Activation of glucagon-like peptide-1 receptors and skilled reach foraging","volume":"26","author":"Vestlund","year":"2020","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1439203","article-title":"The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius","volume":"15","author":"Edvardsson","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib49","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/cne.23282","article-title":"Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication","volume":"521","author":"Gu","year":"2013","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2026.04.022_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110303","article-title":"The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: A review","volume":"110","author":"Guerrero-Hreins","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.04.022_bib51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2026.04.022_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104778","article-title":"The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naive male mice","volume":"124","author":"Vestlund","year":"2020","journal-title":"Horm Behav"},{"key":"10.1016\/j.biopsych.2026.04.022_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104687","article-title":"Glucagon-like peptide-1 receptors and sexual behaviors in male mice","volume":"117","author":"Vestlund","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib54","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib55","doi-asserted-by":"crossref","first-page":"E1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.04.022_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbr.2012.08.021","article-title":"Affective taste responses in the presence of reward- and aversion-conditioned stimuli and their relationship to psychomotor sensitization and place conditioning","volume":"236","author":"Cagniard","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2026.04.022_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.physbeh.2017.10.017","article-title":"The GHR-R antagonist JMV 2959 neither induces malaise nor alters the malaise property of LiCl in the adult male rat","volume":"183","author":"Rodriguez","year":"2018","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.04.022_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2017.05.024","article-title":"Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior","volume":"123","author":"Mietlicki-Baase","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib59","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1038\/npp.2014.153","article-title":"Amylin receptor signaling in the nucleus accumbens negatively modulates \u03bc-opioid-driven feeding","volume":"39","author":"Baisley","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.04.022_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115613","article-title":"Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease","volume":"213","author":"Mahalingam","year":"2023","journal-title":"Biochem Pharmacol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326012230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326012230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:49:58Z","timestamp":1794563398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326012230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0006322326012230"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.04.022","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}